Live Breaking News & Updates on Novel Residual Risk Subtype Identifies Patients

Stay updated with breaking news from Novel residual risk subtype identifies patients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PreludeDx™ to Present DCISionRT® and Novel Residual Risk Subtype Study Results During Scientific Oral Session at ASBrS 2022 Annual Meeting

/PRNewswire/ Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that. ....

United States , Pat Whitworth , G Bruce Mann , Andrew Wade , Cory Dunn , Frank Vicini , Prnewswire Prelude Corporation Preludedx , National Cancer Institute , Nashville Breast Center , American Society Of Breast Surgeons Asbr , Prelude Corporation , University Of California San Francisco , Residual Risk Subtype , American Society , Breast Surgeons , Scientific Session Oral Presentations , Novel Residual Risk Subtype Identifies Patients , Varying Risk , Among Younger , High Grade , Nashville Breast , Friday April , Identifies Two Subsets , Significantly Different Risk , Local Recurrence , Novel Biologic Subtype Was Predictive ,